US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, ...

Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

Hitting a plateau after a steady run of weight loss has derailed many health and fitness plans. But what if you could flick a ...

As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...

If we could develop a medication that helps maintain fat or sugar burning at its original high level alongside weight-loss ...

Many people who have tried to lose weight by cutting calories are familiar with this frustrating reality: At some point, the ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...